Skip to search formSkip to main contentSkip to account menu

Doxorubin

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
pH-sensitive micelles are considered promising carriers for tumor targeted drug delivery. In this study, novel pH-sensitive star… 
Review
2011
Review
2011
1099 Background: Increasing data are available regarding treating women diagnosed with breast cancer during pregnancy with… 
2010
2010
The 4′-epidaunorubicin is the semisynthesis precursor of epirubicin which is a clinically useful antitumor drug thought to have… 
Highly Cited
2007
Highly Cited
2007
Doxorubicin is an excellent chemotherapeutic agent utilized for several types of cancer but the irreversible doxorubicin-induced… 
2007
2007
Purpose: Thymidine phosphorylase (TP) induction by docetaxel is a proposed mechanism for the observed preclinical synergy of… 
2006
2006
17504 Background: We have recently reported that a combination of bortezomib (Velcade), liposomal doxorubicin (Doxil), and… 
1999
1999
OBJECTIVE To study the effects of estradiol (E2) and medroxyprogesterone acetate (MPA) on the growth of drug resistant human… 
1998
1998
HER2 (erbB-2) proto-oncogene amplification and/or overexpression correlate with poor prognosis in many malignancies. The precise… 
1982
1982
Fifteen patients with advanced stage D hormone-resistant prostate cancer were treated with the combination of doxorubicin…